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In Niger, the epidemiological situation regarding foot-and-mouth disease is unclear since many 
outbreaks are unreported. This study aimed i) to identify FMDV strains currently circulating in 
cattle herds, and ii) to identify risk factors associated with FMD seropositive animals in clinical 
outbreaks. Epithelial tissues (n=25) and sera (n=227) were collected from cattle in eight districts 
of the southwestern part of Niger. Testing of clinical material revealed the presence of FMDV 
serotype O that was characterised within the O/WEST AFRICA topotype. The antigenic 
relationship between one of the FMDV isolates from Niger (O/NGR/4/2015) and three 
reference vaccine strains was determined by the two-dimensional virus neutralization test 
(2dmVNT), revealing a close antigenic match between the field isolate from Niger and three 
FMDV serotype O vaccine strains. Serological analyses using a non-structural protein (NSP) 
test provided evidence for previous FMDV infection in 70% (158/227) of the sera tested. 
Multivariate logistic regression analysis revealed that only the herd composition (presence of 
both cattle and small ruminants) was significantly associated with FMDV seropositivity as 
defined by NSP positive results (P-value = 0.006). Of these positive sera, subsequent testing by 
Liquid Phase Blocking ELISA (LPBE) showed that 86% (136/158) were positive for one (or 
more) of four FMDV serotypes (A, O, SAT 1 and SAT 2). This study provides epidemiological 
information about FMD in the southwestern part of Niger, and highlights the complex 
transboundary nature of FMD in Africa. These findings may help to develop effective control 
and preventive strategies for FMD in Niger as well, as other countries in West Africa. 
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Introduction 
 
Foot-and-mouth disease (FMD) is a highly contagious transboundary disease of cloven-hoofed 
domestic and wild animals caused by FMD virus (FMDV) belonging to the Aphthovirus genus 
within the Picornaviridae family. FMDV is a small, non-enveloped, icosahedral virus that has 
a positive-sense, single-stranded RNA genome of approximately 8.5 kb that encodes a single 
polyprotein which is cleaved into four structural proteins (SP) and 10 non-structural proteins 
(NSPs) by virus encoded proteases (Belsham, 1993). FMDV exists in seven immunologically 
distinct serotypes, O, A, C, Asia 1, SAT (Southern African Territories) 1, SAT 2 and SAT 3, 
each with a wide range of antigenically distinct subtypes. (Gleeson, 2002; Kasambula et al., 
2012; Knowles & Samuel, 2003).  
 
FMD is endemic in Niger where clinical disease has been reported mainly in cattle (Couacy-
Hymann et al., 2006; Sangare et al., 2001; Sangare et al., 2004a). FMD was first reported in 
Niger in 1945, when samples corresponding to serotype C were typed by the Laboratoire 
Central de Recherches Vétérinaires of Maisons-Alfort in France (Pagot, 1948). According to a 
retrospective study that reviewed FMD outbreaks occurring between 1971 and 2001 (Couacy-
Hymann et al., 2006), four FMDV serotypes (namely O, A, SAT 1 and SAT 2) were suspected 
to be present in West African countries including Niger. Other published studies support the 
circulation of these four FMD serotypes in the region (Fasina et al., 2013; Gorna et al., 2014; 
Olabode et al., 2014; Sangare et al., 2001; Sangare et al., 2003; Sangare et al., 2004a, Sangare 
et al., 2004b; Ularamu et al., 2016), although a comprehensive understanding of FMD 
epidemiology that can be used to inform disease control programs is currently lacking. 
Unfortunately, livestock in Niger have never been vaccinated against FMD. Moreover, as the 
livestock production system is mostly characterized by transhumance, nomadism and trade with 
neighbouring countries, there are no restrictions on animal movements in the country or 
elsewhere in West African. Therefore, the objectives of this study were to identify FMDV 
strains responsible for outbreaks in the southwestern part of Niger that occurred in cattle in 
2014, as well as to describe risks factors associated with FMDV seropositivity in animals from 
these herds.  
 
 
Materials and methods 
Study area 
In this article, sampling locations were defined at the district-level (Niger is administratively 
divided into 8 regions, 63 departments and 265 districts). The study was conducted in eight 
districts in the southwestern part of the country that included three regions namely Niamey (the 
capital), Tillabery and Dosso.  
 
It is in the region of Tillabery that the largest numbers of samples were obtained in four districts: 
Kollo located 35 km from Niamey, Makalondi, Tamou and Alambaré bordering with Burkina 
Faso. In addition, Tamou and Alambaré are located near the W Regional Park which is a major 
national park in West Africa (Niger, Burkina Faso and Benin) around a meander in the River 
Niger shaped like a "W". In the Dosso region, three districts were involved in the study, 
including Dole, Tanda and Gaya, which share a common border with Nigeria and Benin. In 
Niamey, one district (called the fourth Arrondissement) was involved. Except for Niamey's 
district, these localities are located either on the transhumance route towards Benin and Nigeria 
(districts of Tanda, Dole and Gaya), or towards Burkina Faso and Benin (districts Tamou, 
Alambaré and Makalondi). This zone covers an area of more than 29,000 km² with a cattle 
population of about 500,000 animals (representing 5% of the cattle population at national level) 
based on the latest livestock census in 2007. Agriculture and livestock are the main activities 
of the resident population. The study area is depicted in Figure 1. 
 
Insert figure 1: Geographical locations of FMD outbreaks described in this study 
 
Sampling design and disease investigation 
In this study, an outbreak was defined as a district from which one or more clinical cases of 
FMD were reported by the district animal health service and/or by the farmers themselves. 
During September to October 2014, all reported outbreak sites were visited as soon as possible 
after notification; epithelium and serum samples were collected from cattle in the described 
study area. 
 
As far as we are aware, no FMDV vaccination or other control measures were implemented at 
the study sites as in other parts of the country. The animals were first examined for evidence of 
salivation and lameness. Salivating and/or lame animals were restrained in a crush pen for 
thorough examination and sampling. The oral cavity of salivating animals was examined for 
evidence of intact and/or ruptured vesicles, erosions and ulcers on the tongue, dental pad and 
mucosa. The hooves of lame animals were thoroughly washed with water and carefully 
examined for lesions, particularly on the coronary bands and interdigital spaces of the hooves. 
The epithelium samples were taken from sick animals showing suspected clinical signs and 
lesions of FMD, while the sera were taken from all examined animals during the herd visit, 
including those on which epithelium samples were collected (Table 1). 
 
Insert Table 1: Overview of the sampling strategy 
 
Sample and data collection  
Twenty-five epithelium tissues were collected from oral and foot lesions from suspected FMD-
infected cattle in seven separate districts: Makalondi (n=7), Gaya (n=2), Dolé (n=1), Tanda 
(n=1), Kollo (n=7), Alambaré (n=5) and Tamou (n=2). After collection, the tissues were 
immediately placed in a virus transport media composed of equal amount of sterile glycerol 
(50% v/v) and 0.04 M phosphate buffered saline (PBS) at a pH between 7.2 and 7.6. 
At the same time, 227 blood samples were collected from apparently healthy and from clinically 
affected cattle. Sera were collected in eight districts (seven mentioned above and in one of the 
districts of Niamey): Makalondi (n=38), Gaya (n=5), Dolé (n=19), Tanda (n=17), Kollo (n=48), 
Alambaré (n=14), Tamou (n=10) and Niamey (n=51). In the last district, Niamey, the FMD 
outbreak was notified at least three weeks after the occurrence of the active outbreak and at the 
time of the visit there were neither clinical signs nor lesions in affected cattle. The samples 
(serum and epithelium) were transported to the National Veterinary Laboratory of Niamey 
(LABOCEL) on dry ice. At LABOCEL, samples were stored at -20°C (serum) and at -80°C 
(epithelium) until their shipment to the Botswana Vaccine Institute (BVI) laboratory for 
analyses. All specimens were packaged as described by Kitching and Donaldson (1989) and 
shipped in a transport media to the BVI laboratory in Gaborone, Republic of Botswana. Among 
the epithelium tissues, positive samples diagnosed at BVI were submitted for confirmation to 
the World Reference Laboratory for FMD (WRLFMD) at The Pirbright Institute, UK. 
 
Data were collected using a questionnaire (see Appendix 1), which was used to interview 
farmers responsible for 28 herds (with a total of 227 sampled animals) selected on the basis of 
FMD outbreak notification. The recorded data included animal age, sex and location, and the 
presence or absence of clinical signs and lesions in cattle. In addition, the interview collected 
information regarding FMD risk factors such as the number of animals in the herd, the herd 
composition, the grazing and watering habits, the herd management (transhumance nomadic or 
sedentary), and the potential contact with wildlife.  
 
Serological analysis 
Detection of antibodies against FMDV non-structural proteins (NSP-ELISA) 
Serological diagnostics were performed at the Botswana Vaccine Institute (BVI) in accordance 
to the established standards and practices of this OIE reference laboratory for Sub-Saharan 
Africa. Sera were initially screened for antibodies against the highly conserved NSP of FMDV 
using the PrioCHECK® FMDV NS Enzyme-Linked Immunosorbent Assay (ELISA) test kit 
(Prionics AG, Switzerland), following the manufacturer’s protocol. The Optical Density at 
450nm (OD450) values of all samples were expressed as Percentage of Inhibition (PI) relative 
to the OD450 max. Positive results were defined as samples that generated a PI value of ≥50, 
whereas a strong positive result was set at a PI value of ≥70.  
 
Detection of serotype-specific antibodies against FMDV Liquid-phase blocking ELISA 
(LPBE) 
NSP ELISA positive reactive sera were further assessed using the Liquid-Phase Blocking 
ELISA (LPBE) modified from Hamblin et al. (1986). Briefly, ELISA plates NUNC Maxisorp 
(Gibco, Cat#4-39454A) were coated with FMDV serotype-specific rabbit hyperimmune sera 
(serotypes O, A, SAT1 and SAT2 suspected to be present in Niger), and left overnight in a 
humid chamber at room temperature. In carrier plates, 2-fold series of each test serum were 
prepared, from 1/16 to 1/128. Control sera (strong and weak positive, and negative) were diluted 
at 1/16. To each well of the carrier plate, 50 µl the different FMDV serotype viral antigen was 
added at a pre-determined working dilution, resulted in a ratio of sera with FMD antigen starting 
from 1/32 to 1/256. The following day, the rabbit antiserum-coated ELISA plates were washed 
three times with phosphate buffered saline containing 0.05% Tween 20 (PBST) (pH 7.4), and 
serum/antigen mixtures were transferred from the carrier plates to the rabbit-serum–coated 
ELISA plates and incubated at 37ºC for 1 hour on a rotary shaker. The plates were then washed 
three times as previously and FMDV serotype-specific guinea pig antiserum was added to each 
well at a predetermined working concentration and incubated at 37 °C for 1 hour on a rotary 
shaker. After incubation and washing step as previously, rabbit anti-guinea pig immunoglobulin 
conjugated to horseradish peroxidase was added to each well at a predetermined working 
concentration. The plates were washed after 1 hour of incubation and substrate solution 
(orthophenylene diamine [OPD] + 0.05% H2O2) was added to each well. The reaction was 
stopped by adding 50μl of 1 M sulfuric acid. The plates were read at 492 nm on a Thermo 
Scientific™ Multiskan™ FC Microplate Photometer and antibody titres were expressed as the 
final dilution of the tested serum giving 50% of the mean absorbance value in the virus control 
wells where test serum was absent. Titres of less than 1/40 (or 1.6 in reciprocal log10 form) were 
considered as negative while titres more than 1/40 were considered positive (Hamblin et al., 
1986). 
 
Analysis of epithelium tissues 
Virus isolation 
The epithelium tissues were processed by the standard WRLFMD/World Organisation for 
Animal Health (OIE) procedure for virus isolation (OIE, 2012). The composition of the media 
used for virus isolation and culture of cells is as follows: 10% Minimum Essential Medium 10X 
(MEM 10X), 10% Lactalbumin Hydrolysate 10X, 4.5% Sodium Bicarbonate, 1% Negative Calf 
serum, 0.2% Penicillin and top up to 100ml with sterile distilled water. The epithelium samples 
were first taken from the PBS/glycerol, and blotted dry on absorbent paper. A suspension was 
prepared by grinding 1 gram of the sample in sterile sand in a sterile pestle and mortar with a 
small volume of tissue culture medium. Medium was added until a final volume of nine times 
that of added epithelial sample was reached, giving a 10% suspension. The suspension was 
clarified on a bench centrifuge at 3,700 RPM for 10 minutes at 4°C. The clarified suspensions 
suspected to contain FMDV were inoculated onto primary lamb kidney cell cultures (Rein de 
Mouton [RM]: at BVI) or primary bovine thyroid cell cultures (BTy: at WRLFMD) and 
incubated for 1 hour at 37 °C. Fresh cell culture medium was then added (15 ml); the cultures 
were incubated at 37 °C and monitored for cytopathic effect (CPE) for 48 hours. If no CPE was 
observed after 48 hours, the sample was considered as ‘no virus detected’ the culture was frozen 
at -70°C, then thawed and centrifuged at 3,700 RPM for 10 minutes at 4°C to collect supernatant 
for second passage (P2), this was repeated for third passage (P3) and if no CPE was observed 
at 48hrs, then the sample was considered negative for FMDV. The first passage (P1) and the 
second passage (P2) were subject to one freeze-thaw cycle. If CPE was observed, the culture 
medium was pooled and cleared by centrifugation at 3,700 RPM for 10 minutes at 4°C. A 
sample of supernatant was tested by RT-PCR following RNA extraction. However, it should 
be noted that the samples were examined for virus isolation nine months after they had been 
collected in the field. 
 
Conventional RT-PCR assay for VP1 analysis 
RNA was extracted from the ground tissue suspension samples using ZR Viral RNA kit 
(ZymoResearch, USA) following the manufacturer’s instructions. Extracted nucleic acid 
samples were analysed for FMDV RNA using conventional reverse transcription-polymerase 
chain reaction (RT-PCR) using oligonucleotide forward primer O-1C244F (5'-
GCAGCAAAACACATGTCAAACACCTT-3') and reverse primer EUR 2B-52R (5'-
GACATGTCCTCCTGCATCTGGTTGAT-3') targeting the VP1 gene within the FMDV RNA 
genome (Knowles et al., 2016). At the BVI, the RT-PCR was set and ran as following: reverse 
transcription at 48ºC for 30 minutes; the initial denaturation at 94ºC for 1 minute; 40 cycles 
(denaturation at 94ºC for 15 seconds; annealing at 60ºC for 30 seconds; extension at 68ºC for 1 
minute); a final extension at 68ºC for 5 minutes and then hold at 4ºC. Amplification products 
were separated on a 1.5% agarose gel and visualised by Gel Red staining and UV irradiation. 
One-step RT-PCR at the WRLFMD was performed as previously described (Knowles et al., 
2016). 
 
Sequencing and phylogenetic analysis 
The RT-PCR amplicons were sequenced on both strands as previously described (Knowles et 
al., 2016). The sequences were assembled and verified using SeqMan software (DNAStar, 
Lasergene v.8). VP1 nucleotide sequences were aligned by using BioEdit version 7.2.5 (Hall, 
1999) and Clustal W (Thompson et al., 1994).  
 
The comparison and midpoint-rooted Neighbor-joining trees of FMDV VP1 sequences from 
Niger with those from Africa available in the NCBI GenBank database 
(www.ncbi.nlm.nih.gov) were performed using MEGA 6.06 (Tamura et al., 2013). The 
robustness of tree topology was assessed with 1000 bootstrap replicates by using the model in 
MEGA 6.06. Bootstrap values of >70 are shown at the relevant major nodes. Sequences 
showing 100% nucleotide identity in VP1 were classified as a single genetic variant. The 
complete VP1 nucleotide sequences generated in this study corresponding to each genetic 
variant but also collected from a specific geographic location were submitted to the NCBI 
GenBank database under the accession numbers (KX424677-KX424682).  
Vaccine Strain Selection 
Vaccine strain selection for serotype O isolates was performed at WRLFMD by two-
dimensional virus neutralization test (2D-VNT). The vaccines used in this study were provided 
by international vaccine manufacturers (Merial Animal Health and Merck Animal Health). The 
2D-VNT test was carried out using the pooled post-vaccination monovalent bovine vaccine sera 
(BVS) collected after 21 days post-vaccination of naïve animals. Briefly, the BVS was tested 
against both the homologous (vaccine strains) and the heterologous (field strain). Antibody 
titres of the reference serum against the homologous (reference) and heterologous (field) viruses 
for five virus doses were calculated, and a linear regression line was drawn (Minitab program) 
to allow the log10 reciprocal antibody dilution required for 50% neutralization of 100 tissue 
culture infective units (TCID50) of virus to be calculated. The antigenic relationship between 
the field strain and the reference strain was then expressed as an 'r1' value based on the following 
equation: “Reciprocal log10 of (heterologous titre – homologous titre)” (Rweyemamu et al., 
1976). An r value of >0.3 suggests that the vaccine virus may protect against the field strain 
(Paton et al., 2005). 
 
Statistical analysis 
In a first step, a multilevel mixed-effects model was used to take into account the possible herd 
and/or district levels as random effects. Because random effects were not observed, logistic 
regression was used to model the odds of being NSP positive as a function of investigated 
potential exposure risk factors. Initial screening of potential risk factors for FMD was 
performed by univariate regression (Hosmer & Lemeshow, 2000). Secondly a multivariate 
logistic regression using backward stepwise analysis was used to check the relationship between 
NSP positive results and explanatory variables (Petrie, 2006). The following explanatory 
variables and their respective reference classes were used: province of origin of the herd (4th 
Arrondissement as reference), herd type (nomadism or transhumance as reference), herd size 
(continue variable), herd composition (only cattle as reference), contact with wildlife (rare as 
reference), transhumance destination (inside the country as reference), detection for FMD cases 
after the transhumance (yes as reference), gender (male as reference), age (≤ 2 years as 
reference), animal origin (birth inside the herd as reference), clinical signs (presence as 
reference) and lesions (presence as reference). In addition, to assess the collinearity, a backward 
elimination of variables was performed (Preux, 2005). If a variable induced a modification of 
the odds ratio of more than 20%, this variable was retained in the final model where the 
interaction was tested in case of biological relevance. Goodness of fit was assessed using the 
Hosmer–Lemeshow goodness-of-fit test. Statistical analyses were performed using STATA/SE 
Acad. 14 (Stata Corp., College Station, Texas, USA). 
 
Results 
Characteristics of sampled animal 
A total of 227 cattle including 93 males (41%) and 134 females (59%) belonging to 28 herds 
(20 transhumant or nomadic herds and 8 sedentary herds) were sampled during the period 
between September 4, 2014 and October 16, 2014. Most of the sampled animals were relatively 
young as the age of 58% (n=132) was estimated between 0 and 2 years, while 42% (n=95) had 
an estimated age between 3 and 4 years or more. Only 15% (n=33) of the sampled animals were 
introduced into their respective herds from outside, via purchase from livestock markets. With 
respect to animal species composition, 7 out of the 28 of the sampled herds were composed 
only of cattle, while the 21 of the other herds were mixed (8 herds with cattle and small 
ruminants and 13 herds with cattle, small ruminants and other animals such as poultry, camels 
and horses). In Makalondi District, a single mixed herd included pigs. All the sampled animals 
of the selected herds mixed with animals of other herds of neighbouring districts during grazing 
and access to water points. According to herdsmen, in more than half of the selected herds 
(54%, n=15), clinical cases of FMD were reported when the cattle came back from 
transhumance. Of the total of 227 animals tested, 38 animals (17%) exhibited both clinical signs 
and lesions of FMD. Accordingly, it was among these 38 animals that sufficient epithelium 
samples were taken from 25 sick cattle.  
 
Serological analysis 
Using the NSP ELISA test, 70% (158/227) of sera were positive for the presence of antibodies 
against FMDV. There was random distribution of positive animals among age classes (Chi-
square (3 df) = 6.12; p = 0.11). The seroprevalence of animals of the age group between 3 and 
4 years (83%) was not significantly higher than the prevalence of animals of other age 
categories (70%, 62% and 65% for ≤ 2 years, > 2 and ≤ 3 years and > 4 years respectively) 
Table 2.  
 
Insert Table 2: NSP ELISA positive animals by age class 
 
Among the NSP ELISA positive sera tested by LPBE, 86% (136/158) were positive for one or 
more serotypes (A, O, SAT 1 and SAT 2). Based on the distribution of seroprevalence by 
sampling site, the highest serological prevalence was for serotype O observed in 7/8 districts 
(except the district of Tamou) (Figure 2). 
 
Insert Figure 2: Liquid Phase Blocking ELISA results based on geographical locations of 
FMD outbreaks 
 
In addition, either as single or as multiple serological reactions, there was a clear dominance of 
serotype O followed by serotypes A and SAT1. However, only 11.3% (n=18) of NSP ELISA 
positive samples yielded positive results for a single serotype: against serotypes A (5 samples), 
SAT1 (4 samples) or O (9 samples), while 86.1% (n=136) were positive for 2 or more serotypes, 
and only 2.5% (n=4) generated negative results with the LPBE (Figure 3 and Appendix 2). 
 
Insert Figure 3: Prevalence of single or multiple FMDV serotypes detected in LPBE  
 
Factors associated with FMDV seropositivity based on a logistic regression analysis 
The results of univariate regression analysis for odds of being NSP ELISA positive as a function 
of investigated potential exposure risk factors showed that only the herd composition (presence 
of both cattle and small ruminants) was highly significantly associated with FMDV 
seropositivity (p = 0.002; Table 3). The remaining variables were not significantly associated 
with FMDV seropositivity at the 5% level, but those with a p-value ≤ 0.2 were considered as 
potential risk factors and therefore entered in the multivariable analysis model (herd 
composition, district of origin and age of animals).  
 
Insert Table 3: Potential risk factors associated with FMDV seropositivity based on a 
univariate logistic regression model 
 
Multivariate analysis including all variables (with a p-value less than 0.20 after univariate 
analysis) exploited a final model that included district and herd composition as variables. Herd 
composition was significantly associated with FMDV positivity (p = 0.006). The Hosmer–
Lemeshow test showed that this final model fitted the data well (Chi-square = 1.81; df = 6, P-
value = 0.94). The interaction between the two retained variables was not tested because of the 
lack of biological relevance (Table 4). 
 
Insert Table 4: Final model of risk factors associated with FMDV seropositivity based on a 
multivariate logistic regression model 
 
Isolation and identification of FMDV 
Thirteen of the 25 epithelial samples produced CPE during one, two or three passages on 
primary lamb kidney cell cultures at BVI. These samples were from the districts of Tamou (3), 
Gaya (2), Makalondi (2) and Kollo (6). By antigen ELISA (performed at the WRLFMD), 
FMDV serotype O was identified in cell culture harvests from seven epithelia collected in Gaya 
(n=1), Makalondi (n=2) and Kollo (n=4) districts. Based on the sequence comparison using 
BLAST, the serotype identification of these samples was in concordance with the Ag-ELISA 
results. The other six samples (from the 13 CPE positive samples) were detected negative by 
both antigen ELISA and PCR tests. Sequences were obtained for six of the seven isolates of 
FMDV serotype O, and these are included in the phylogenetic analysis and listed in Table 5 
 
Insert Table 5: Diagnostic results on epithelium samples collected in Niger in 2014 and the 
GenBank accession number of VP1 sequences 
 
Phylogenetic analysis  
From FMDV isolates collected in 2014, amplicons corresponding to the complete VP1 coding 
region were generated by RT-PCR and sequenced for six of the virus isolates. These sequences 
were compared with others from NCBI, GenBank and results from phylogenetic analyses 
revealed that they all belonged to the topotype O/West Africa (WA). Those isolated from Kollo 
district (NGR/4/2015, NGR/21/2015 and NGR/24/2015) had pairwise alignment (nt) identities 
of 99.3% - 99.7% with each other while the viruses isolated from Makalondi (NGR/15/2015 
and NGR/16/2015) had 100% nt identity with each other. The FMDV isolate from Gaya 
(NGR/11/2015) had pairwise nt identity of 99.0% - 99.4% with other isolates from other 
districts. The VP1 sequences from Niger were compared to those available in the GenBank 
database (Figure 4). The analysis revealed that the Niger isolates are mostly related to the 
FMDV from Benin [O/BEN/40/2010 (KC832986) with 95.2% to 95.8% nt identity and 
O/BEN/26/2010 (KC832981) with 94.2% to 95.8% nt identity], Togo [O/TOG/1/2004 
(KX258038) with 90.3% to 92.3% nt identity and O/TOG/1/2005 (KX258039) with 92.1% nt 
identity] and from Ghana [O/Lam/GHA/2012 (KF305227) with 90.3% to 90.9% nt identity] all 
being classified within the type O/WA topotype. However, the Niger FMDV isolates show 
lower relationship values with other earlier West African FMDV serotype O isolates from Côte 
d’Ivoire [O/CIV/8/99 (AJ303485) with 88.9% to 90.4% nt identity] and from Ghana 
[O/GHA/5/93 (AJ303488) with 85.8% to 87.4% nt identity] (Figure 4).  
 
Insert Figure 4: Midpoint-rooted Neighbor-joining tree showing the relationship between the 
VP1 sequences of serotype O isolated in Niger 
 
Vaccine Strain Selection 
The antigenic relationship between one of the FMDV isolates from Niger (O/NGR/4/2015) and 
three reference vaccine strains were determined by the two-dimensional virus neutralization 
test (2D-VNT). The results presented (Table 6) revealed that there is a close antigenic 
relationship between the three FMDV serotype O vaccine strains and Niger’s FMDV serotype 
O field isolate. The calculated ‘r1’ value was greater than the minimum requirement (>0.3) for 
especially the two vaccine strains (O3039 and O/TUR/5/2009).  
 




This study reports on serological and molecular information for FMD outbreaks in southwest 
Niger based on samples collected from cattle in September and October 2014. FMD is endemic 
in most parts of Africa and only few countries in the south of the continent have managed to 
control the disease (Brito et al., 2015; Vosloo et al., 2002), while only sporadic cases of FMD 
are regularly reported (Brito et al., 2015; Tekleghiorghis et al., 2016). Niger with an area of 
1,267,000 km2, is one of the largest West African countries. Based on the general census of 
agriculture and livestock in 2007, the cattle population was estimated at more than 7 million of 
heads. However, despite the important role of the livestock sector in Niger (La Rovere et al., 
2005; Turner & Williams, 2002), this industry is continuously challenged with multiple 
constraints such as the persistence of animal diseases, including FMD. Although FMD 
outbreaks have been reported every year, the veterinary authorities and farmers have placed 
little emphasis to FMD. Hence, even though FMD is on the list of monitored animal diseases 
in epidemio-surveillance networks, there is still an under-reporting of FMD outbreaks. The 
main purpose of this study was to characterize FMD viruses responsible for clinical cases and 
additionally to have an overview of circulating FMDV antibodies in livestock associated with 
risk factors analysis. This was only the justification of the adopted sampling method that can 
be designated as a “convenience sampling” consisting therefore to sample suspected sick 
animals (for epithelial tissues) and both the suspected sick animals and apparently healthy 
animals (for sera) in the all reported infected herd (as soon as possible after the rare notification 
of outbreaks). However, despite the limited nature of sampling, this study could certainly have 
the value to update data on FMD in a country where the epidemiological status of the disease 
is poorly understood. 
 
The serological results indicate that FMDV is endemic within the livestock population in the 
study area, suggesting that multiple FMDV serotypes (such as A, O, SAT 1 and SAT 2) may 
be involved as has been shown elsewhere in the West African region (Brito et al., 2015; Di 
Nardo et al., 2011; Ehizibolo et al., 2014; Fasina et al., 2013; Gorna et al., 2014). Using the 
budget available for this study, serological testing (by LPBE) was designed to detect four 
different FMDV serotypes (A, O, SAT 1 and SAT 2) suspected to be present in Niger. Further 
studies may be warranted to also include serotypes C and SAT 3, although serotype C has not 
been detected in any country since 2004. SAT 3-specific antibodies have been recorded in sera 
from west and central Africa (Ehizibolo et al., 2014; Ludi et al., 2016) and from eastern Africa 
(Ayebazibwe et al., 2010; Dhikusooka et al., 2015; Mwiine et al., 2010; Namatovu et al., 2015), 
although this serotype has not previously been detected in Niger. Although the sampling 
strategy is different to that implemented by Ludi et al, (2016), our results appear to be similar 
regarding the presence of different serotypes in unvaccinated animals. Serological tests also 
reveal that antibodies to four FMDV serotypes were present among the animals sampled 
although only one FMDV serotype (O) was detected by viral isolation and sequencing. The 
presence of animals with single serological reactivity to serotypes A and SAT 1 (Figure 3) may 
indicate either past exposure to these FMDV, or may arise as a result of cross-reactivity among 
serotypes in the LPBE (Hedger et al, 1982; Jackson et al., 2007). Future serological studies are 
warranted to these results. 
 
Since 2005, only O and SAT 2 serotypes have been isolated in Niger, serotype A having been 
isolated for the last time in 1973 and SAT1 in 1976 (WRLFMD, 2016b). In this study, the 
highest serological prevalence was that of serotype O (89%), followed by serotypes SAT 1, A 
and SAT 2. Serotype O was detected in more than 80% of samples from all selected districts 
where FMD outbreaks occurred. Furthermore, for individual districts, serotype O was most 
frequently detected, except in Gaya and Tanda Districts where serotype A (at 33%) and serotype 
SAT1 (at 45%) were found, respectively. Interestingly, specific response to serotype O was 
obtained in cattle from 3/7 districts, namely Tamou, Kollo and Niamey. Additionally, in 
Niamey where the epithelium sampling was not possible due to the delay in the notification of 
the FMD outbreak, five sera were specifically positive to serotype O. The serological results 
for serotype O, could be interpreted as significant for this study because the serotype O was the 
only FMDV detected positive through viral isolation test. However, there is no evidence about 
any conclusion regarding the serological responses by the fact that the adopted sampling 
scheme is not consistent to make an accurate statement on statistical inference of results. 
 
There was no association between seropositivity and age. Generally, keeping young animals 
around the homestead or in areas separated from adult animals helps to decrease their exposure 
to FMDV (Bayissa et al., 2011; Bronsvoort et al., 2006; Molla et al., 2010). However, the 
relative high seropositivity of FMDV antibodies in cattle of all age groups as observed in this 
study, combined with the spatial distribution of the herds over all of the districts in the study 
area, suggests that there is frequent infection with FMDV in this part of Niger. 
 
In epidemiological settings, such as Niger with the existing livestock management practices, all 
potential risk factors could contribute to FMD infection. However, the statistical analysis 
showed that only the herd composition (cattle mixed with small ruminants) was highly 
significantly associated with FMDV seropositivity in FMD outbreaks. Despite these results, the 
role of other factors should not be ignored. The role of transhumance in FMD spread has been 
shown to play an important role elsewhere in sub-Saharan Africa (Rweyemamu et al., 2008). 
Furthermore, significant buffalo populations exist in West and Central Africa, including the W 
park (trans-border area shared between Benin, Burkina Faso and Niger). Notably, two districts 
in the study area (Alambaré and Tamou) are located at the interface zone between domestic 
animals and wildlife through the national park W of Niger. To what extent types of FMDV 
prevalent in domestic ruminants infect wildlife is unknown, and this important pattern of the 
FMD transmission dynamics remains to be more explained (Ayebazibwe et al., 2010; Di Nardo 
et al., 2015; Vosloo et al., 2002; Anderson et al., 1993; Fevre et al., 2006). Furthermore, there 
are important rural livestock markets in the study area (for example Alambaré), where contact 
between animals increases by absence of any quarantine measure and where subsequently the 
transmission of FMD virus and other animal diseases is enhanced (Dean et al., 2013; Garland 
& de Clercq 2011). It is obvious that the effect of the potential risk factors would be more 
clearly reflected with a comprehensive random sampling in domestic animals as well as in 
wildlife. 
 
Out of the total analysed epithelium samples (n=25), only six VP1 sequences were obtained for 
phylogenetic analysis. This relatively low rate (6/25) of sequence recovery could be explained 
by several factors such as the insufficient quality of the samples with degradation of the 
genome, due to a long time of storage of samples - about 10 months - and to poor shipping 
conditions or, on the other hand, by the lower analytical sensitivity of the sequencing VP1 RT-
PCRs or primer mismatches. Furthermore, the relative lower quality of epithelium tissue 
samples could likewise be the reason that one FMDV isolate was recovered among the four 
samples sent to the WRLFMD. The failure to isolate FMDV from more samples restricted the 
extent of vaccine matching work that could be performed at the WRLFMD. Further work is 
urgently required to expand these vaccine-matching studies to more field isolates from the 
country. Furthermore, these in vitro results would benefit from results of in vivo pilot studies 
that evaluate the performance of the vaccine in the target host species. 
 
During the last ten years, serotype O field isolates have been characterized in Burkina Faso, 
Togo, Nigeria, Ghana, Cameroon, Senegal, Mali and Niger. VP1 sequence analysis undertaken 
in this study indicates that these FMD viruses from Niger are closely related to strains 
previously isolated in West Africa. These isolates display the closest relationship with the 
strains from Benin (O/BEN/40/2010 and O/BEN/26/2010), Togo (O/TOG/1/2004 and 
O/TOG/1/2005), and from Ghana (O/Lam/GHA/2012). This close genetic relationship supports 
the role of cross-border animal movements are a major route by which FMD spreads in the 
region (Brito et al., 2015; Bronsvoort et al., 2004b; Couacy-Hymann et al., 2006; Di Nardo et 
al., 2011; Ehizibolo et al., 2014; Fasina et al., 2013; Gorna et al., 2014; Knowles & Samuel, 
2003; WRLFMD, 2016a). In addition to the uncontrolled movement of animals along the 
border, to our knowledge, countries such as Benin and Togo do not practice mass vaccination 
against FMD. 
 
In conclusion, the serological and molecular observations of this study urge for continuous 
surveillance of FMD enabling to monitor the infection status and the spread of FMDV serotypes 
in livestock as well as in wildlife populations in Niger. It is anticipated that the results of this 
study despite its limited sampling design will motivate further work to characterise FMDV from 
field outbreaks in the country where the epidemiological status of the disease is poorly 
understood. In addition, regarding to transboundary animal movements and international 
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Table and figure captions 
 
Table 1: Overview of the sampling strategy 
Legend: a: Epithelium samples collected from sick animals with existing oral and foot lesions, 
b: sera collected from all examined animals during the herd visit, including those on which 
epithelium samples were collected. i + j = total number of sampled animals during the herd visit 
that correspond to the total number of sera. 
Table 2: NSP ELISA positive animals by age class  
Legend: Sampled cattle were classified into 4 age group, this table shows the seroprevalence of 
animals of each age class, 70% represent the overall seroprevalence yielded by NSP ELISA. 
Table 3: Potential risk factors associated with FMDV seropositivity based on a univariate 
logistic regression model 
Legend: * P-value less than 0.05, OR: Odds Ratio, CI: Confidence Interval. 
Table 4: Final model of risk factors associated with FMDV seropositivity based on a 
multivariate logistic regression model 
Legend: * P-value less than 0.05, OR: Odds Ratio, CI: Confidence Interval. 
Table 5: Diagnostic results on epithelium samples collected in Niger in 2014 and the GenBank 
accession number of VP1 sequences 
Legend: P: passage; FMDV-GD: FMDV genome detected; Age class: 0: ≤ 2 years; 1: >2 and ≤ 3 years; 
2: >2 and ≤ 4 years; 3: > 4 years. Epithelium tissues (n=25) were obtained from clinical FMD cattle 
originating from seven districts of southwestern of Niger. This table indicates the positive diagnostic 
(virus isolation, Ag-ELISA and PCR) results with high quality sequences (n=6). These positives samples 
were from the following districts: Gaya (GY), Makalondi (MK) and Kollo (KL). 
Table 6: ‘r1’ values obtained between FMDV serotype O field isolates and vaccine strains 
Legend: An ‘r1’ value greater than 0.3 indicates the existence of close antigenic relationship 
between the vaccine strain and the field isolate. 
 
Figure 1: Geographical locations of FMD outbreaks described in this study 
Legend: Administrative regions: 1: Agadez, 2: Diffa, 3: Dosso, 4: Maradi, 5: Tahoua, 6: 
Tillabery, 7: Zinder and Niamey (capital city). Study area (Eight sampling districts described 
in this study): Niamey, Kollo, MK: Makalondi, Gaya (that covers administratively the district 
of Tanda, Dole) and Tamou (covering administratively Alambaré). 
 Figure 2: Liquid Phase Blocking ELISA results based on geographical locations of FMD 
outbreaks 
Legend: 4e Arrd is one the district of Niamey called the fourth Arrondissement. Sera (n=227) 
were collected in 8 districts of southwestern of the country. LPBE test was performed on NSP 
ELISA positive samples (n=158). 
Figure 3: Prevalence of single or multiple FMDV serotypes detected in LPBE 
Legend: The LPB ELISA test was performed on NSP ELISA positive samples (n=158). The 
total sera represent 227 samples from both subclinical and clinical cattle. Neg: Negative, A: 
single response to serotype A, O: single response to serotype O, SAT1: single response to 
serotype SAT1, SAT2:  single response to serotype SAT2, the remaining are multiple responses 
to FMDV serotypes (see Appendix 2). 
Figure 4: Midpoint-rooted Neighbor-joining tree showing the relationship between the VP1 
sequences of serotype O isolated in Niger 
Legend: WA=West Africa; ME-SA= Middle-Est and South Africa. 
 
  
Table 1: Overview of the sampling strategy 
Sampling 
site 
Number of herds 
visited 
Number of 
sick animals i 
Number of apparently 
healthy animals j 
Number of Samples 
collected 
    
Epitheliuma Serumb 
Makalondi 6 32 13 7 45 
Gaya 1 4 3 2 7 
Dolé 4 8 12 1 20 
Tanda 2 9 9 1 18 
Alambaré 2 11 8 5 19 
Tamou 3 2 10 2 12 
Kollo 5 26 29 7 55 
4e Arrd 
(Niamey) 
5 27 24 0 51 
Total 28 119 108 25 227 
Legend: a: Epithelium samples collected from sick animals with existing oral and foot lesions, 
b: sera collected from all examined animals during the herd visit, including those on which 
epithelium samples were collected. i + j = total number of sampled animals during the herd visit 





Table 2: NSP ELISA positive animals by age class  




≤ 2 years 74 52 70 
> 2 and ≤ 3 years 58      36 62 
> 3 and ≥ 4 years 47 39 83 
> 4 years 48 31 65 
Total 227 158 70 
Legend: Sampled cattle were classified into 4 age group, this table shows the seroprevalence of 












Table 3: Potential risk factors associated with FMDV seropositivity based on a univariate 
logistic regression model 
Variable Modality OR 95% CI P-value 






















Herd type Nomadism or 
transhumance 




Herd size (continue variable) Size 1.001.827 0.99-
1.01 
0.48 
Herd composition Only cattle Ref. - - 












Transhumance destination Inside the country Ref. - - 
Outside the country 0.71 0.14-
3.75 
0.69 








Detection of FMD cases after the 
transhumance 










Age ≤ 2 years Ref. - - 
Between 2 and 3 years 0.69 0.33-
1.43 
0.32 
Between 3 and 4 years 2.06 0.83-
5.12 
0.12 
≥ 4 years 0.77 0.36-
1.67 
0.51 
Animal origin  Birth inside the herd Ref. - - 
Birth outside the herd 0.85 0.39-
1.87 
0.69 










Legend: * P-value less than 0.05, OR: Odds Ratio, CI: Confidence Interval. 
 
  
Table 4: Final model of risk factors associated with FMDV seropositivity based on a 
multivariate logistic regression model 
Variable Modality OR 95% CI P-value 
Commune 4th 
Arrondissement 
Ref. - - 
 
Alambaré 0.79 (0.24-2.54) 0.70 
 
Dolé 2.02 (0.51-8.07) 0.32 
 
Gaya 1.09 (0.15-7.80) 0.93 
 
Kolo 1.49 (0.47-4.77) 0.50 
 
Makalondi 1.96 (0.57-6.72) 0.29 
 
Tamou 7.04 (0.70-70.97) 0.10 
 
Tanda 0.86 (0.28-2.60) 0.79 





3.99 (1.47-10.82) 0.006* 
  Other 2.66 (0.85-8.34) 0.10 





















Table 5: Diagnostic results on epithelium samples collected in Niger in 2014 and the 1 











































































Legend: P: passage; FMDV-GD: FMDV genome detected; Age class: 0: ≤ 2 years; 1: >2 and ≤ 3 years; 3 
2: >2 and ≤ 4 years; 3: > 4 years. Epithelium tissues (n=25) were obtained from clinical FMD cattle 4 
originating from seven districts of southwestern of Niger. This table indicates the positive diagnostic 5 
(virus isolation, Ag-ELISA and PCR) results with high quality sequences (n=6). These positives samples 6 




  11 
31 
 
Table 6: ‘r1’ values obtained between FMDV serotype O field isolates and vaccine strains 12 




O3039 O Manisa O/TUR/5/2009 
Field isolate (O/NGR/4/2015) 0.63 0.36 0.6 
Legend: An ‘r1’ value greater than 0.3 indicates the existence of close antigenic relationship 13 
between the vaccine strain and the field isolate. 14 
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Fig. 3 24 
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Appendix 1: Sampling sheet for FMD (Translated from French to English) 30 
 31 
Background information 32 
 Number of Sample: ......................................................Date:…../……/……… 33 
 34 
 Region:…………….Department:…….…………Commune:……………….... Locality:…. 35 
 Geographic coordinates:      Longitude:………Latitude:…………………… 36 
 Owner's name:  37 
 38 
Animal identification 39 
 40 
 Sexe: Male              Female 41 
 42 
 Age 43 
Age category 
<2 years [2 - 3 years[ [3 - 4 years[ > 4  years 
    
 44 
 Animal origin 45 
Born in the herd:  Yes            No              46 
Introduced from other area: Yes          No              47 
 48 
 Herd composition 49 
Herd of only cattle:  Yes          No              50 
Herd of cattle, sheep and goat: Yes          No            51 
Herd of cattle, sheep, goat and other domestics animals:   Yes          No            52 
 53 
 Grazing habit of livestock  54 
Grazing all neighbors  livestock together as one herd: Yes          No            55 
Grazing house hold herd separetly: Yes          No            56 
Mixing at watering points: Yes          No            57 
39 
 
Herd not mixed at watering / watered at different site: Yes          No         58 
 59 
 Contact history to wildlife 60 
Herd have contact  to wild animals usually:     Yes      No  61 
Have contact only rarely:  Yes      No  62 








 Do you usually conduct your herd to transhumance: 71 
Yes      No  72 
 73 
If so, what is the main destination of  transhumance? 74 
 75 
 Neighboring region  Neighboring district   Some where in the country (Niger)  Neighboring 76 
country  (Which one?) 77 
 78 
 79 
  After returning from transhumance in your district, have you had some FMD cases? 80 
         Yes      No  81 
 82 
 83 
 Clinical signs, type of lesions observed and samples taken  84 
 85 
Clinical signs Type of lesions Samples taken 
40 
 































Appendix 2: Individual serological response to NSP ELISA and LPBE tests 91 
 92 
Sample ID PI (NSP) LPB ELISA titration results 
 
  A O SAT1 SAT2 Result interpretation 
 MK1 67 1.54 1.93 1.84 1.94 OSAT1SAT2 
 MK2 81 1.40 1.92 1.69 1.95 OSAT1SAT2 
 MK3 91 1.76 1.93 1.78 1.94 AOSAT1SAT2 
 MK4 95 1.93 1.92 1.94 1.95 AOSAT1SAT2 
 MK5 94 1.78 1.91 1.85 1.94 AOSAT1SAT2 
 MK7 91 1.94 1.92 1.62 1.89 AOSAT1SAT2 
 MK8 87 1.74 1.90 1.71 1.95 AOSAT1SAT2 
 MK9 72 1.77 1.90 1.85 1.56 AOSAT1  
 MK10 85 1.88 1.93 1.93 1.95 AOSAT1SAT2 
 MK11 95 1.85 1.87 1.80 1.94 AOSAT1SAT2 
 MK12 91 1.93 1.90 1.88 1.93 AOSAT1SAT2 
 MK13 87 1.71 1.93 1.81 1.94 AOSAT1SAT2 
 MK15 95 1.91 1.93 1.87 1.84 AOSAT1SAT2 
 MK16 65 1.41 1.92 1.77 1.92 OSAT1SAT2 
 MK24 83 1.76 1.79 1.75 1.73 AOSAT1SAT2 
 MK25 91 1.51 0.93 1.84 1.28 SAT1 
 MK26 65 1.22 1.56 1.43 1.57 Negative 
 MK27 97 1.93 0.82 1.87 1.17 ASAT1 
 MK28 90 1.93 1.93 1.95 1.52 AOSAT1 
 MK30 62 1.94 1.92 1.84 1.58 AOSAT1 
 MK31 79 1.93 1.48 1.90 1.46 ASAT1 
 MK32 96 1.94 1.93 1.86 1.95 AOSAT1SAT2 
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 MK33 56 1.82 1.95 1.91 1.91 AOSAT1SAT2 
 MK35 79 1.90 1.88 1.91 1.32 AOSAT1 
 MK36 97 1.94 1.93 1.94 1.95 AOSAT1SAT2 
 MK38 92 1.90 1.87 1.78 1.92 AOSAT1SAT2 
 MK39 72 1.74 1.84 1.78 1.04 AOSAT1 
 MK40 78 1.87 1.89 1.87 1.86 AOSAT1SAT2 
 MK42 80 0.99 1.49 1.71 0.51 SAT1 
 MK44 73 1.58 1.92 1.75 1.93 OSAT1SAT2 
 MK45 56 1.32 1.90 1.91 1.45 OSAT1  
GY2 61 1.49 1.92 1.79 1.73 OSAT1SAT2 
GY3 95 1.56 1.94 1.86 1.97 OSAT1SAT2 
GY5 93 1.74 1.91 1.76 1.95 AOSAT1SAT2 
GY8 88 1.62 1.82 1.67 1.97 OSAT2 
GY10 76 1.94 1.94 1.72 1.78 AOSAT1SAT2 
GY12 88 1.93 1.94 1.93 1.58 AOSAT1 
GY13 93 1.93 1.92 1.88 1.76 AOSAT1SAT2 
GY14 90 1.82 1.87 1.85 1.88 AOSAT1SAT2 
GY15 84 1.49 1.94 1.76 1.49 OSAT1 
GY16 66 1.93 1.95 1.72 1.82 AOSAT1SAT2 
GY17 78 1.93 1.95 1.93 1.58 AOSAT1 
GY20 87 1.79 1.92 1.92 1.80 AOSAT1SAT2 
GY21 76 1.93 1.94 1.81 1.72 AOSAT1SAT2 
GY22 69 1.84 1.93 1.37 1.51 AO 
GY23 86 1.83 1.94 1.91 1.81 AOSAT1SAT2 
GY24 94 1.91 1.93 1.53 1.78 AOSAT2 
GY25 94 1.88 1.93 1.52 1.22 AO 
GY26 89 1.54 1.58 0.57 1.01 Negative 
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GY27 78 1.53 1.95 1.89 1.71 OSAT1SAT2 
GY28 92 1.83 1.93 1.59 1.54 AO 
GY29 89 1.70 1.93 1.57 1.73 AOSAT2 
GY30 91 1.94 1.31 1.59 1.06 A 
GY32 68 1.75 1.93 1.43 1.26 AO 
GY37 92 1.41 0.86 1.49 1.27 Negative 
GY38 73 1.72 1.94 1.52 1.49 AO 
GY39 92 1.95 1.94 1.92 1.58 AOSAT1 
GY40 51 1.84 1.94 1.52 1.26 AO 
GY41 84 1.36 1.94 1.71 1.82 OSAT1SAT2 
GY42 67 1.91 1.93 1.89 1.93 AOSAT1SAT2 
GY45 98 1.57 1.56 1.77 1.10 SAT1 
TM2 78 1.05 1.56 1.79 1.42 SAT1 
TM3 95 1.94 1.92 1.92 1.89 AOSAT1SAT2 
TM4 93 1.90 1.93 1.85 1.95 AOSAT1SAT2 
TM5 95 1.94 1.93 1.85 0.72 AOSAT1 
TM6 70 1.44 1.90 1.80 1.52 OSAT1 
TM11 88 1.59 1.89 1.56 1.57 O 
TM12 92 1.94 1.93 1.58 1.75 AOSAT2 
TM13 59 1.47 1.91 1.91 1.70 OSAT1SAT2 
TM15 68 1.90 1.85 1.91 1.82 AOSAT1SAT2 
TM16 95 1.92 1.93 1.81 1.97 AOSAT1SAT2 
TM18 96 1.28 1.93 1.79 1.97 OSAT1SAT2 
TM19 69 1.78 1.94 1.89 1.85 AOSAT1SAT2 
TM20 83 1.95 1.94 1.89 1.90 AOSAT1SAT2 
TM21 51 1.71 1.14 1.51 1.52 A 
TM22 74 1.93 1.93 1.93 1.78 AOSAT1SAT2 
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TM23 63 1.77 1.94 1.89 1.71 AOSAT1SAT2 
TM24 63 1.90 1.23 1.56 1.51 A 
TM25 89 1.82 1.75 1.90 1.97 AOSAT1SAT2 
TM26 94 1.94 1.48 1.91 1.85 ASAT1SAT2 
TM27 91 1.76 1.92 1.47 1.84 AOSAT2 
TM28 76 1.29 1.92 1.46 1.81 OSAT2 
TM29 67 1.34 1.91 1.84 1.86 OSAT1SAT2 
TM30 96 1.87 1.93 1.82 1.86 AOSAT1SAT2 
KL51 74 1.45 1.92 1.87 1.85 OSAT1SAT2 
KL53 89 1.40 1.91 1.89 1.84 OSAT1SAT2 
KL52 75 1.89 1.80 1.90 1.54 AOSAT1 
NY52 76 1.38 1.82 1.51 1.46 O 
NY54 87 1.44 1.88 1.87 1.85 OSAT1SAT2 
NY53 80 1.52 1.93 1.44 0.79 O 
KL1 55 1.13 1.89 1.83 1.87 OSAT1SAT2 
KL2 71 1.40 1.93 1.89 0.54 OSAT1 
KL3 85 1.80 1.46 1.49 1.29 A 
KL4 87 1.48 1.93 1.86 1.85 OSAT1SAT2 
KL6 65 1.78 1.92 1.83 1.55 AOSAT1 
KL7 68 1.38 1.88 1.84 1.42 OSAT1 
KL8 54 1.91 1.94 1.81 1.82 AOSAT1SAT2 
KL9 87 1.36 1.88 1.77 1.84 OSAT1SAT2 
KL10 69 1.93 1.90 1.72 1.79 AOSAT1SAT2 
KL11 77 1.93 1.93 1.86 1.39 AOSAT1 
KL12 95 1.84 1.93 1.88 1.94 AOSAT1SAT2 
KL13 86 1.87 1.92 1.85 1.83 AOSAT1SAT2 
KL14 78 1.94 1.87 1.85 1.80 AOSAT1SAT2 
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KL16 59 1.87 1.92 1.92 1.76 AOSAT1SAT2 
KL17 64 1.93 1.91 1.83 1.41 AOSAT1 
KL18 95 1.29 1.91 1.44 1.94 OSAT2 
KL19 77 1.95 1.92 1.83 1.83 AOSAT1SAT2 
KL20 85 1.18 1.93 1.51 0.68 O 
KL21 77 1.30 1.89 1.84 0.99 OSAT1 
KL23 74 1.52 1.92 1.86 1.77 OSAT1SAT2 
KL25 96 1.90 1.92 1.91 1.94 AOSAT1SAT2 
KL26 95 1.85 1.91 1.76 1.27 AOSAT1 
KL28 95 1.75 1.94 1.88 1.87 AOSAT1SAT2 
KL31 69 1.90 1.92 1.82 1.72 AOSAT1SAT2 
KL32 66 1.52 1.91 1.76 1.17 OSAT1 
KL33 78 1.49 1.92 1.55 1.47 O 
KL34 80 1.79 1.85 1.75 1.17 AOSAT1 
KL35 81 1.31 1.92 1.11 1.54 O 
KL37 63 1.56 1.93 1.31 1.84 OSAT2 
KL38 93 1.91 1.93 1.41 1.91 AOSAT2 
KL39 65 1.90 1.92 1.86 1.84 AOSAT1SAT2 
KL40 70 1.76 1.90 1.46 0.60 AO 
KL45 71 1.25 1.86 1.90 1.89 OSAT1SAT2 
KL46 69 1.80 1.90 1.92 1.85 AOSAT1SAT2 
KL48 83 1.86 1.91 1.56 1.86 AOSAT2 
KL49 90 1.91 1.87 1.83 1.36 AOSAT1 
KL50 99 1.86 1.88 1.90 1.84 AOSAT1SAT2 
NY1 91 1.95 1.94 1.93 1.97 AOSAT1SAT2 
NY2 69 1.86 1.95 1.83 1.88 AOSAT1SAT2 
NY3 54 1.74 1.93 1.91 1.71 AOSAT1SAT2 
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NY4 67 1.82 1.94 1.84 1.77 AOSAT1SAT2 
NY5 77 1.46 1.94 1.81 1.49 OSAT1 
NY6 67 1.85 1.93 1.89 1.88 AOSAT1SAT2 
NY7 95 1.71 1.93 1.91 1.97 AOSAT1SAT2 
NY10 64 1.93 1.93 1.85 1.79 AOSAT1SAT2 
NY12 93 1.93 1.91 1.87 1.86 AOSAT1SAT2 
NY13 69 1.77 1.94 1.44 1.97 AOSAT2 
NY15 86 1.93 1.95 1.94 1.93 AOSAT1SAT2 
NY16 91 1.94 1.94 1.77 1.80 AOSAT1SAT2 
NY17 63 1.78 1.94 1.55 1.54 AO 
NY18 66 1.79 1.93 1.83 1.76 AOSAT1SAT2 
NY19 90 1.84 1.93 1.40 1.28 AO 
NY20 78 1.79 1.92 1.80 1.83 AOSAT1SAT2 
NY21 67 1.93 1.94 1.75 1.85 AOSAT1SAT2 
NY22 67 1.56 1.95 1.45 1.98 OSAT2 
NY25 78 1.74 1.94 1.42 1.16 AO 
NY27 71 1.94 1.50 1.39 1.56 A 
NY29 84 1.78 1.94 1.72 1.73 AOSAT1SAT2 
NY32 57 1.54 1.87 1.49 1.52 O 
NY33 74 1.40 0.95 1.46 1.18 Negative 
NY34 80 1.85 1.31 1.84 1.78 ASAT1SAT2 
NY35 71 1.79 1.92 1.41 1.82 AOSAT2 
NY37 67 1.93 1.94 1.86 1.89 AOSAT1SAT2 
NY38 57 1.84 1.94 1.46 1.86 AOSAT2 
NY40 57 1.20 1.94 0.25 1.33 O 
NY41 61 1.38 1.94 -1.05 1.44 O 
NY42 87 1.90 1.42 1.24 1.84 ASAT2 
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NY45 50 1.84 1.94 1.56 1.85 AOSAT2 
Legend: Sera were collected in 8 districts of south-western of Niger: Makalondi (MK), Gaya (GY), 93 
Kollo (KL), Tamou (TM) and Niamey (NY). Sera from Dolé and Tanda were included as originating 94 
from Gaya (administrative subdivision that covers these districts), likewise, sera collected in Alambaré 95 
were considered as from Tamou that is the administrative subdivision covering this district. Antibody 96 
titres were expressed as the final dilution of the tested serum giving 50% of the mean absorbance value 97 
in the virus control wells where test serum was absent. Titres of less than 1.6 (in inverse log10 form) 98 
were considered as negative while titres more than 1.6 were considered positive (Hamblin et al., 1986). 99 
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